Small Stocks, Big Money™

Gorilla Technology Group (Nasdaq: GRRR) and BroadSat Technologies have joined forces to deliver cutting-edge Smart Connectivity and AI-driven Cybersecurity solutions. This strategic partnership targets the $150 billion Smart Cities and cybersecurity markets in the U.S. and EMEA, leveraging the $42.45 billion Broadband Equity, Access, and Deployment (BEAD) Program to bridge the digital divide. The collaboration will advance broadband access in underserved regions, empower Smart Cities, and accelerate innovation through Gorilla's AI expertise and BroadSat's connectivity leadership. Together, the companies aim to redefine digital infrastructure and create lasting community impact.

Nexalin Technology’s (Nasdaq: NXL) proprietary Deep Intracranial Frequency Stimulation (DIFS) technology is prominently featured in a newly published editorial in Psychotherapy and Psychosomatics. This peer-reviewed article provides compelling validation of Nexalin’s ability to non-invasively treat challenging psychiatric conditions, highlighting the Company’s unique positioning in the rapidly growing neuromodulation market, which is projected to reach $11.0 billion by 2028.

Greenwich LifeSciences (Nasdaq: GLSI) has partnered with Gruppo Italiano Mammella (GIM), Italy’s largest academic breast cancer research network, to expand its Phase III FLAMINGO-01 trial evaluating GLSI-100, an immunotherapy aimed at preventing breast cancer recurrence. Nine leading Italian institutions have been activated, reflecting strong local support for this innovative HER2-targeted therapy. With breast cancer accounting for 30% of female cancers in Italy, the partnership underscores the trial’s significance in addressing high relapse rates while reinforcing Greenwich’s commitment to global collaboration in combating breast cancer.

ASP Isotopes (NASDAQ: ASPI) has completed construction of its Silicon-28 enrichment facility in South Africa and is now entering commissioning to prepare for commercial deliveries by mid-2025. Silicon-28, critical for quantum computing and next-generation semiconductors, will be produced at a capacity exceeding 50 kilograms annually, far surpassing initial estimates. With two U.S. customer agreements already secured and discussions ongoing with global buyers, ASPI’s proprietary enrichment technology promises higher purity without additional chemical conversions, positioning the company as a key player in advancing faster, smaller, and more efficient chips for AI and quantum applications.